Long-term oxygen therapy has been proven to improve survival in COPD patients with severely impaired oxygenation. However, does the COPD patient with moderately impaired oxygenation also benefit from supplemental long-term oxygen therapy? The Long-Term Oxygen Treatment Trial (LOTT), a randomized clinical trial published in 2016, was designed to evaluate the efficacy of supplemental oxygen for this patient population. This presentation will discuss the design and results of the multi-center LOTT and the implications on patient care.
This Live AARC webcast is approved for 1.0 CRCE
Speaker: Jerry Krishnan MD, PhD
This webcast is sponsored by an unrestricted educational grant from ResMed Inc.
9425 N. MacArthur Blvd, Suite 100, Irving, TX 75063-4706(972) 243-2272 | info@aarc.org
Member ServicesMember BenefitsAARC State Societies
About UsAARC OfficiaryCode of Conduct